Education, Science, Technology, Innovation and Life
Open Access
Sign In

High-flow nasal cannula and interface- or mode-specific noninvasive ventilation in acute hypoxemic respiratory failure: an endpoint-harmonized systematic review and Bayesian network meta-analysis of randomized trials

Download as PDF

DOI: 10.23977/medsc.2026.070208 | Downloads: 8 | Views: 91

Author(s)

Fujing Yang 1, Yunchuan Zhong 1, Qiuyan Yu 1

Affiliation(s)

1 Department of Emergency, First People's Hospital of Neijiang, Neijiang, China

Corresponding Author

Qiuyan Yu

ABSTRACT

Previous meta-analyses of noninvasive respiratory support for acute hypoxemic respiratory failure (AHRF) have often treated noninvasive ventilation (NIV) as a single intervention and have pooled non-comparable intubation outcomes. We updated the randomized evidence base and reassessed comparative effectiveness after harmonizing standalone intubation endpoints and separating NIV according to interface and ventilation mode. Embase, PubMed, the Cochrane Library, and Web of Science were searched from inception to March 7, 2026 for randomized controlled trials in adults with AHRF. The primary outcome was short-term standalone endotracheal intubation reported during the index hospitalization or by day 28-30; composite endpoints, including intubation-or-death, were excluded from the primary efficacy network. Thirty-seven randomized trials involving 6,592 participants were retained in the evidence base, and 28 trials involving 5,583 participants informed the primary endpoint-harmonized network. Compared with standard oxygen therapy (SOT), short-term standalone intubation was reduced with helmet NIV (odds ratio [OR] 0.20, 95% credible interval [CrI] 0.09-0.43), high-flow nasal cannula (HFNC; OR 0.54, 95% CrI 0.34-0.80), and face-mask NIV (OR 0.56, 95% CrI 0.37-0.79). In the prespecified 6-node network, helmet bilevel NIV showed the largest estimated effect versus SOT (OR 0.12, 95% CrI 0.05-0.29). Restriction to strict day-28/day-30 standalone intubation attenuated effect sizes but did not change the direction of effect. No active strategy was associated with a credible reduction in day-28/day-30 mortality. In adults with AHRF, HFNC, face-mask NIV, and helmet NIV each reduced short-term standalone intubation compared with SOT after endpoint harmonization; the apparent helmet benefit was driven mainly by helmet bilevel NIV. Mortality data remain too sparse for firm comparative conclusions. 

KEYWORDS

Acute hypoxemic respiratory failure; High-flow nasal cannula; Noninvasive ventilation; Helmet NIV; Bayesian network meta-analysis; Endotracheal intubation

CITE THIS PAPER

Fujing Yang, Yunchuan Zhong, Qiuyan Yu. High-flow nasal cannula and interface- or mode-specific noninvasive ventilation in acute hypoxemic respiratory failure: an endpoint-harmonized systematic review and Bayesian network meta-analysis of randomized trials. MEDS Clinical Medicine (2026). Vol. 7, No.2, 51-60. DOI: http://dx.doi.org/10.23977/medsc.2026.070208.

REFERENCES

[1] Munshi L., Mancebo J., Brochard L.J. (2022) Noninvasive Respiratory Support for Adults with Acute Respiratory Failure. N Engl J Med, 18, 1688-1698.
[2] Brochard L., Slutsky A., Pesenti A. (2017) Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. American Journal of Respiratory and Critical Care Medicine, 4, 438-442.
[3] Slutsky A.S., Ranieri V.M. (2013) Ventilator-induced lung injury. N Engl J Med, 22, 2126-2136.
[4] Mauri T., Turrini C., Eronia N., Grasselli G., Volta C.A., Bellani G., et al. (2017) Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med, 9, 1207-1215.
[5] Nishimura M. (2016) High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects. Respir Care, 4, 529-541.
[6] Patel B.K., Wolfe K.S., Pohlman A.S., Hall J.B., Kress J.P. (2016) Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. Jama, 22, 2435-2441.
[7] Ferreyro B.L., Angriman F., Munshi L., Del Sorbo L., Ferguson N.D., Rochwerg B., et al. (2020) Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis. JAMA, 1, 57-67.
[8] Frat J.P., Thille A.W., Mercat A., Girault C., Ragot S., Perbet S., et al. (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 23, 2185-2196.
[9] Perkins G.D., Ji C., Connolly B.A., Couper K., Lall R., Baillie J.K., et al. (2022) Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. Jama, 6, 546-558.
[10] Pitre T., Zeraatkar D., Kachkovski G.V., Leung G., Shligold E., Dowhanik S., et al. (2023) Noninvasive Oxygenation Strategies in Adult Patients With Acute Hypoxemic Respiratory Failure: A Systematic Review and Network Meta-Analysis. Chest, 4, 913-928.
[11] Hutton B., Salanti G., Caldwell D.M., Chaimani A., Schmid C.H., Cameron C., et al. (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med, 11, 777-784.
[12] Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj.
[13] Sterne J.A.C., Savović J., Page M.J., Elbers R.G., Blencowe N.S., Boutron I., et al. (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj, l4898.
[14] Maia I.S., Kawano-Dourado L., Tramujas L., de Oliveira N.E., Souza R.N., Signorini D.F., et al. (2025) High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial. Jama, 10, 875-890.
[15] Plummer M., editor JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003); 2003.
[16] van Valkenhoef G., Lu G., de Brock B., Hillege H., Ades A.E., Welton N.J. (2012) Automating network meta-analysis. Res Synth Methods, 4, 285-299.
[17] Spiegelhalter D.J., Best N.G., Carlin B.P., van der Linde A. (2002) Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 4, 583-639.
[18] Gelman A., Rubin D.B. (1992) Inference from iterative simulation using multiple sequences. Statistical Science, 4, 457-472.
[19] Salanti G., Ades A.E., Ioannidis J.P.A. (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of Clinical Epidemiology, 2, 163-171.
[20] Balduzzi S., Rücker G., Nikolakopoulou A., et al. (2023) netmeta: an R package for network meta-analysis using frequentist methods. Journal of Statistical Software, 106, 1-40.
[21] Egger M., Davey Smith G., Schneider M., Minder C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 7109, 629-634.
[22] Chaimani A., Higgins J.P.T., Mavridis D., Spyridonos P., Salanti G. (2013) Graphical Tools for Network Meta-Analysis in STATA. PLoS ONE, 10, e76654.
[23] Dias S., Welton N.J., Caldwell D.M., Ades A.E. (2010) Checking consistency in mixed treatment comparison meta-analysis. Statistics in Medicine, 7-8, 932-944.
[24] Nikolakopoulou A., Higgins J.P.T., Papakonstantinou T., Chaimani A., Del Giovane C., Egger M., et al. (2020) CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Medicine, 4, e1003082.
[25] Agmy G., Adam M., Hsanen E.H., Mahmoud M.A. (2022) High-flow nasal cannula versus noninvasive ventilation in the prevention of escalation to invasive mechanical ventilation in patients with acute hypoxemic respiratory failure. The Egyptian Journal of Chest Diseases and Tuberculosis, 1, 81-87.
[26] Al Hashim A.H., Al Reesi A., Al Lawati N.M., Burad J., Al Khabori M., Chandwani J., et al. (2023) Comparison of noninvasive mechanical ventilation with high-flow nasal cannula, face-mask, and helmet in hypoxemic respiratory failure in patients with COVID-19: a randomized controlled trial. Critical Care Medicine, 11, 1515-1526.
[27] Alptekinoğlu Mendil N., Temel Ş., Yüksel R.C., Gündoğan K., Eser B., Kaynar L., et al. (2021) The use of high-flow nasal oxygen vs. standard oxygen therapy in hematological malignancy patients with acute respiratory failure in hematology wards. Turk J Med Sci, 4, 1756-1763.
[28] Andino R., Vega G., Pacheco S.K., Arevalillo N., Leal A., Fernández L., et al. (2020) High-flow nasal oxygen reduces endotracheal intubation: a randomized clinical trial. Ther Adv Respir Dis, 1753466620956459.
[29] Artaud-Macari E., Bubenheim M., Le Bouar G., Carpentier D., Grangé S., Boyer D., et al. (2021) High-flow oxygen therapy versus noninvasive ventilation: a randomised physiological crossover study of alveolar recruitment in acute respiratory failure. ERJ Open Res, 4.
[30] Azevedo J., Montenegro W., Leitao A., Silva M., Prazeres J., Maranhao J. (2015) High flow nasal cannula oxygen (HFNC) versus non-invasive positive pressure ventilation (NIPPV) in acute hypoxemic respiratory failure. A pilot randomized controlled trial. Intensive Care Medicine Experimental, Suppl 1, A166.
[31] Azoulay E., Lemiale V., Mokart D., Nseir S., Argaud L., Pène F., et al. (2018) Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. Jama, 20, 2099-2107.
[32] Bouadma L., Mekontso-Dessap A., Burdet C., Merdji H., Poissy J., Dupuis C., et al. (2022) High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial. JAMA Intern Med, 9, 906-916.
[33] Brambilla A.M., Aliberti S., Prina E., Nicoli F., Forno M.D., Nava S., et al. (2014) Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia. Intensive care medicine, 7, 942-949.
[34] Confalonieri M., Potena A., Carbone G., Porta R.D., Tolley E.A., Umberto Meduri G. (1999) Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation. American journal of respiratory and critical care medicine, 5, 1585-1591.
[35] Cosentini R., Brambilla A.M., Aliberti S., Bignamini A., Nava S., Maffei A., et al. (2010) Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial. Chest, 1, 114-120.
[36] Coudroy R., Frat J.P., Ehrmann S., Pène F., Decavèle M., Terzi N., et al. (2022) High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med, 7, 641-649.
[37] Delclaux C., L'Her E., Alberti C., Mancebo J., Abroug F., Conti G., et al. (2000) Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial. Jama, 18, 2352-2360.
[38] Doshi P., Whittle J.S., Bublewicz M., Kearney J., Ashe T., Graham R., et al. (2018) High-Velocity Nasal Insufflation in the Treatment of Respiratory Failure: A Randomized Clinical Trial. Ann Emerg Med, 1, 73-83.e5.
[39] Elagamy A.E., Taha S.S., Elfawy D.M. (2021) High flow nasal cannula versus non-invasive ventilation in prevention of intubation in immunocompromised patient with acute hypoxemic respiratory failure. Egyptian Journal of Anaesthesia, 1, 432-439.
[40] Ferrer M., Esquinas A., Leon M., Gonzalez G., Alarcon A., Torres A. (2003) Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med, 12, 1438-1444.
[41] Frat J.P., Quenot J.P., Badie J., Coudroy R., Guitton C., Ehrmann S., et al. (2022) Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial. Jama, 12, 1212-1222.
[42] Grieco D.L., Menga L.S., Cesarano M., Rosà T., Spadaro S., Bitondo M.M., et al. (2021) Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial. Jama, 17, 1731-1743.
[43] Hao J., Liu J., Pu L., Li C., Zhang M., Tan J., et al. (2023) High-flow nasal cannula oxygen therapy versus non-invasive ventilation in AIDS patients with acute respiratory failure: a randomized controlled trial. Journal of Clinical Medicine, 4, 1679.
[44] He H., Sun B., Liang L., Li Y., Wang H., Wei L., et al. (2019) A multicenter RCT of noninvasive ventilation in pneumonia-induced early mild acute respiratory distress syndrome. Crit Care, 1, 300.
[45] Hernandez G., Fernandez R., Lopez-Reina P., Cuena R., Pedrosa A., Ortiz R., et al. (2010) Noninvasive ventilation reduces intubation in chest trauma-related hypoxemia: a randomized clinical trial. Chest, 1, 74-80.
[46] Hilbert G., Gruson D., Vargas F., Valentino R., Gbikpi-Benissan G., Dupon M., et al. (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med, 7, 481-487.
[47] Lemiale V., Mokart D., Resche-Rigon M., Pène F., Mayaux J., Faucher E., et al. (2015) Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial. Jama, 16, 1711-1719.
[48] Martin T.J., Hovis J.D., Costantino J.P., BIERMAN M.I., Donahoe M.P., Rogers R.M., et al. (2000) A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure. American journal of respiratory and critical care medicine, 3, 807-813.
[49] Mirunalini G., Anand K., Pushparani A., Kadirvelu G., KUPPUSAMY A. (2023) Comparison of high flow nasal cannula and continuous positive airway pressure in COVID-19 patients with acute respiratory distress syndrome in critical care unit: a randomized control study. Cureus, 9.
[50] Nagata K., Yokoyama T., Tsugitomi R., Nakashima H., Kuraishi H., Ohshimo S., et al. (2024) Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: a randomized controlled trial. Respirology, 1, 36-45.
[51] Nair P.R., Haritha D., Behera S., Kayina C.A., Maitra S., Anand R.K., et al. (2021) Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia. Respir Care, 12, 1824-1830.
[52] Ospina-Tascón G.A., Calderón-Tapia L.E., García A.F., Zarama V., Gómez-Álvarez F., Álvarez-Saa T., et al. (2021) Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. Jama, 21, 2161-2171.
[53] Saxena A., Nazir N., Pandey R., Gupta S. (2022) Comparison of Effect of Non-invasive Ventilation Delivered by Helmet vs Face Mask in Patients with COVID-19 Infection: A Randomized Control Study. Indian J Crit Care Med, 3, 282-287.
[54] Spoletini G., Mega C., Pisani L., Alotaibi M., Khoja A., Price L.L., et al. (2018) High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: A pilot randomized controlled trial. J Crit Care, 418-425.
[55] Squadrone V., Massaia M., Bruno B., Marmont F., Falda M., Bagna C., et al. (2010) Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med, 10, 1666-1674.
[56] Wermke M., Schiemanck S., Höffken G., Ehninger G., Bornhäuser M., Illmer T. (2012) Respiratory failure in patients undergoing allogeneic hematopoietic SCT—a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone marrow transplantation, 4, 574-580.
[57] Wysocki M., Tric L., Wolff M.A., Gertner J., Millet H., Herman B. (1993) Noninvasive pressure support ventilation in patients with acute respiratory failure. Chest, 3, 907-913.
[58] Zhan Q., Sun B., Liang L., Yan X., Zhang L., Yang J., et al. (2012) Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Critical care medicine, 2, 455-460.
[59] Grieco D.L., Menga L.S., Raggi V., Bongiovanni F., Anzellotti G.M., Tanzarella E.S., et al. (2020) Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med, 3, 303-312.
[60] Arabi Y.M., Aldekhyl S., Al Qahtani S., Al-Dorzi H.M., Abdukahil S.A., Al Harbi M.K., et al. (2022) Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial. Jama, 11, 1063-1072.

Downloads: 11472
Visits: 938976

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.